Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR).
Pietro Di SantoOmar Abdel-RazekRichard JungSimon ParlowAnthony PoulinJordan BernickBaylie MorganLisa RobinsonHannah FeaganJilliane WadeCheng Yee GohKuljit SinghMichael FroeschlMarino LabinazDean A FergussonDoug CoyleKwadwo KyeremantengJoseph AbunassarGeorge A WellsTrevor SimardBenjamin HibbertPublished in: BMJ open (2023)
NCT03630055.